Human medicines European public assessment report (EPAR): Simulect, basiliximab, Graft Rejection,Kidney Transplantation, Date of authorisation: 09/10/1998, Revision: 23, Status: Authorised

2019 ◽  
Author(s):  
Keyword(s):  
Kidney Transplantation ◽  
Graft Rejection ◽  
Assessment Report ◽  
European Public ◽  
European Public Assessment Report
Sign in / Sign up

Export Citation Format

Share Document